Driving neural regeneration through the mammalian target of rapamycin
- Author:
- No author available
- Journal Title:
- Neural Regeneration Research
- Issue:
- 15
- DOI:
- 10.4103/1673-5374.139453
- Key Word:
- Alzheimer’s disease;apoptosis;autophagy;mTOR;necroptosis;rapamycin;stem cells;stroke
Abstract： Neurodegenerative disorders affect more than 30 million individuals throughout the world and lead to signiifcant disability as well as death. These statistics will increase almost exponentially as the lifespan and age of individuals increase globally and individuals become more susceptible to acute disorders such as stroke as well as chronic diseases that involve cognitive loss, Alzheimer’s disease, and Parkinson’s disease. Current therapies for such disorders are effective only for a small subset of individuals or provide symptomatic relief but do not alter disease progression. One exciting therapeutic approach that may turn the tide for addressing neurodegenerative disorders involves the mammalian target of rapamycin (mTOR). mTOR is a component of the protein complexes mTOR Complex 1 (mTORC1) and mTOR Complex 2 (mTORC2) that are ubiquitous throughout the body and control multiple functions such as gene transcription, metabolism, cell survival, and cell senescence. mTOR through its relationship with phosphoinositide 3-kinas e (PI 3-K) and protein kinase B (Akt) and multiple downstream signaling pathways such as p70 ribosomal S6 kinase (p70S6K) and proline rich Akt substrate 40 kDa (PRAS40) promotes neuro-nal cell regeneration through stem cell renewal and oversees critical pathways such as apoptosis, autophagy, and necroptosis to foster protection against neurodegenerative disorders. Targeting by mTOR of speciifc pathways that drive long-term potentiation, synaptic plasticity, andβ-amyl oid toxicity may offer new strategies for disorders such as stroke and Alzheimer’s disease. Overall, mTOR is an essential neuroprotective pathway but must be carefully targeted to maximize clini-cal efifcacy and eliminate any clinical toxic side effects.
- [1]Kenneth Maiese,Zhao Zhong Chong,Yan Chen Shang,etc.Targeting disease through novel pathways of apoptosis and autophagy[J].2012,16(12).
- [2]Yin,B.,Liang,H.,Chen,Y.,etc.EGB1212 post-treatment ameliorates hippocampal CA1 neuronal death and memory impairment induced by transient global cerebral Ischemia/Reperfusion[J].2013,41(6).
- [3]Poliani PL,Alfaro Cervello C,Pala M,etc.Sustained activation of mTOR pathway in embryonic neural stem cells leads to development of tuberous sclerosis complex-associated lesions.[J].2011,9(5).
- [4]Tao, Ma,Charles A, Hoeffer,Estibaliz, Capetillo-Zarate,etc.Dysregulation of the mTOR pathway mediates impairment of synaptic plasticity in a mouse model of Alzheimer's disease.[J].2010,5(9).
- [5]TengJiang,Jin-Tai Yu,Xi-ChenZhu,etc.Temsirolimus promotes autophagic clearance of amyloid-beta and provides protective effects in cellular and animal models of Alzheimer's disease[J].2014,81.
- [6]ZareMehrjerdi,F.,Aboutaleb,N.,Habibey,R.,etc.Increased phosphorylation of mTOR is involved in remote ischemic preconditioning of hippocampus in mice[J].2013,1526.
- [7]Malagelada C,Lopez Toledano MA,Willett RT,etc.RTP801/REDD1 Regulates the Timing of Cortical Neurogenesis and Neuron Migration.[J].2011,31(9).
- [8]Ozawa,H.,Yamaya,S.,Sekiguchi,A.,etc.Rapamycin promotes autophagy and reduces neural tissue damage and locomotor impairment after spinal cord injury in mice[J].2012,29(5).
- [9]Qinli,Z.,Meiqing,L.,Xia,J.,etc.Necrostatin-1 inhibits the degeneration of neural cells induced by aluminum exposure[J].2013,31(5).
- [10]Chen W,Han X,Xu B,etc.Hydrogen peroxide inhibits mTOR signaling by activation of AMPKalpha leading to apoptosis of neuronal cells.[J].2010,90(5).
- [11]Emanuela, Santini,Myriam, Heiman,Paul, Greengard,etc.Inhibition of mTOR signaling in Parkinson's disease prevents L-DOPA-induced dyskinesia.[J].2009,2(80).
- [12]Huang,H.,Huang,F.,Huang,J.-P..Transplantation of bone marrow-derived endothelial progenitorcells overexpressing Delta-like-4 enhances functional neovascularization in ischemic myocardium[J].2013,8(5).
- [13]Reijonen S,Hyrskyluoto A,Kivinen J,etc.GADD34 mediates cytoprotective autophagy in mutant huntingtin expressing cells via the mTOR pathway.[J].2012,318(1).
- [14]Gangloff YG,Thomas G,Mueller M,etc.Disruption of the mouse mTOR gene leads to early postimplantation lethality and prohibits embryonic stem cell development[J].2004,24(21).
- [15]Park CS,Tang SJ,Abbassi NR,etc.Roles of glutamate receptors and the mammalian target of rapamycin (mTOR) signaling pathway in activity-dependent dendritic protein synthesis in hippocampal neurons.[J].2006,281(27).
- [16]Li F,Chong ZZ,Maiese K.New avenues of exploration for erythropoietin.[J].2005,293(1).
- [17]Bae,B.-C.,Moon,M.-H.,Lee,Y.-J.,etc.Autophagy induced by resveratrol prevents human prion protein-mediated neurotoxicity[J].2012,73(2).
- [18]Liu, Xiaona,Chhipa, Rishi Raj,Nakano, Ichiro,etc.The AMPK Inhibitor Compound C Is a Potent AMPK-Independent Antiglioma Agent[J].2014,13(3).
- [19]Choi KC,Kim SH,Ha J.A novel mTOR activating protein protects dopamine neurons against oxidative stress by repressing autophagy related cell death.[J].2010,112(2).
- [20]Maiese,K.,Shang,Y.C.,Wang,S.,etc.Shedding new light on neurodegenerative diseases through the mammalian target of rapamycin[J].2012,99(2).
- [21]Avruch J,Lenz G,Avruch J,etc.Glutamatergic regulation of the p70S6 kinase in primary mouse neurons[J].2005,280(46).
- [22]You,H.,Li,T.,Zhang,J.,etc.Reduction in ischemic cerebral infarction is mediated through golgi phosphoprotein 3 and Akt/mTOR signaling following salvianolate administration[J].2014,11(2).
- [23]Maiese,K.,Chong,Z.Z.,Shang,Y.C.,etc.MTOR: On target for novel therapeutic strategies in the nervous system[J].2013,19(1).
- [24]Cota D,Proulx K,Smith KAB,etc.Hypothalamic mTOR signaling regulates food intake[J].2006,312(5775).
- [25]Jia LS,Shi GD,Shi JG,etc.PTEN deletion prevents ischemic brain injury by activating the mTOR signaling pathway.[J].2011,404(4).
- [26]Zhu,Z.,Yan,J.,Jiang,W.,etc.Arctigenin effectively ameliorates memory impairment in Alzheimer's disease model mice targeting both β-amyloid production and clearance[J].2013,33(32).
- [27]Wang,G.-B.,Ni,Y.-L.,Zhou,X.-P.,etc.The AKT/mTOR pathway mediates neuronal protective effects of erythropoietin in sepsis[J].2014,385(1).
- [28]Balduini,W.,Carloni,S.,Buonocore,G..Autophagy in hypoxia-ischemia induced brain injury[J].2012,25(Suppl.1).
- [29]Kenneth, Maiese,Zhao Zhong, Chong,Jinling, Hou,etc.New strategies for Alzheimer's disease and cognitive impairment.[J].1900,2(5).
- [30]Shang,Y.C.,Chong,Z.Z.,Wang,S.,etc.Tuberous sclerosis protein 2 (TSC2) modulates CCN4 cytoprotection during apoptotic amyloid toxicity in microglia[J].2013,10(1).
- [31]Han J,Wang B,Mao ZF,etc.Mammalian target of rapamycin (mTOR) is involved in the neuronal differentiation of neural progenitors induced by insulin[J].2008,39(1).
- [32]Yan, Haijing,Zhang, Xiangnan,Hu, Weiwei,etc.Histamine H3 receptors aggravate cerebral ischaemic injury by histamine-independent mechanisms[J].2014,5(Feb.).
- [33]Koh,P.-O..Ferulic acid attenuates focal cerebral ischemia-induced decreases in p70S6 kinase and S6 phosphorylation[J].2013,555.
- [34]Maiese,K..Cutting through the complexities of mTOR for the treatment of stroke[J].2014,11(2).
- [35]Johnston JA,Moloney A,O'Connor R,etc.Activation of Akt/PKB, increased phosphorylation of Akt substrates and loss and altered distribution of Akt and PTEN are features of Alzheimer's disease pathology.[J].2005,93(1).